Researchers at The University of Queensland are harnessing the latest sequencing technology developed by UK-based biotech Oxford Nanopore Technologies to analyse mRNA vaccines and therapies. This approach promises to simplify and better ensure the quality of manufactured mRNA-based vaccines and therapeutics worldwide. The BASE team at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) is already recognised as […]
Bionano original equipment manufacturing (OEM) partner Ecobono obtained reagent Class I registration and approval for Bionano’s DNA isolation kits for optical genome mapping (OGM) from China’s National Medical Products Administration (NMPA) Reagents can be utilized for in vitro diagnostics (IVD) use in China With this NMPA registration, Ecobono can sell OGM reagents to independent clinical laboratories and Chinese hospitals SAN DIEGO […]
INTEGRA Biosciences is excited to announce the launch of MIRO CANVAS, a compact digital microfluidics platform for fully automated next generation sequencing (NGS) sample preparation. The revolutionary system drastically simplifies NGS workflows for more walk-away time and higher lab productivity, accelerating genomics discoveries. NGS has made it possible to sequence entire genomes at a fraction […]
BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Amir Jafri, President and CEO of Immunicom, Inc., to its Board of Directors. “Amir’s leadership track record speaks for itself,” said Jeff Hawkins, CEO of Quantum-Si. “He has successfully managed businesses across multiple industries and has built and led […]
Preliminary SpotLight™ Human Lambda reagent data to be showcased by GSK at the 16th annual PEACe Conference EMERYVILLE, Calif. — PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, is pleased to announce that GSK will present data on the SpotLight™ Human Lambda reagent for the Beacon® platform at the 16th annual Conference on Protein Expression in Animal […]
Espoo — Euformatics, a Finnish bioinformatics company that develops world-leading NGS interpretation and quality control tools, announced that it has signed a new commercial partnership with ELTA 90. As part of the collaboration, ELTA 90 and Euformatics plan to locally market the complex clinical diagnostic and genomic testing tools of Euformatics, to benefit the medical […]
San Francisco, CA — Illumina Ventures today announced that Mara Aspinall, MBA, has joined the Company’s investment team as a Partner. “Mara brings more than 30 years of leadership experience in genomics and the diagnostics industry to this position,” said Nick Naclerio, PhD, Illumina Ventures Founding Partner. “Her experience ranges from early-stage start-ups to established public […]
> Dante to utilize Amazon Bedrock to build state-of-the-art large language model (LLM) with broad genomic and clinical applications – > Amazon Bedrock will leverage Dante’s expertise with clinical interpretation and massive whole genome database – > Groundbreaking collaboration pioneering the use case for LLMs in personalized medicine, enabling extraction of phenotypes of interest to […]
The GlutenTox® ELISA Rapid G12 test kit offers a systematic method for evaluating gluten content from wheat, barley and rye in food samples. Its precision and reliability have earned it the AOAC RI Performance Tested MethodsSM certification. The kit aligned with AOAC’s exacting standards, confirming its capability to accurately detect and quantify wheat gluten in a variety of […]
Manufacture of quality-critical materials for the fast-growing and increasingly relevant market segment of cell and gene therapies Groundbreaking event in the Haid-Süd industrial park with around 150 guests Total investment of around 140 million euros Number of jobs can be more than doubled Freiburg, Germany — The life science group Sartorius is building a new […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
